Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 1,694,029 | 1,694,028 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 1,694,029 | 1,694,029 | - | 0 | Class A Common Stock | ||
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 1,694,029 | 0 | - | 0 | Class A Common Stock | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 1,000,000 | 7,198,883 | - | - | Common stock, $0.001 par value per share | |
| Olaplex Holdings Inc | Catherine Dunleavy | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 806,452 | 806,452 | - | 0 | Common Stock | |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 783,355 | 783,355 | - | - | Common Stock | |
| Avalo Therapeutics Inc | Garry A. Neil | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 500,400 | 500,400 | - | - | Stock Option (Right to Buy) | |
| Weave Comm Inc | Tyler Newton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 500,000 | 7,580,533 | - | 0 | Common Stock, par value $0.0001 per share | |
| Bolt Projects Holdings Inc (Class A) | L. Fiddler Jerry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 495,459 | 495,459 | - | - | Common Stock | |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 465,882 | 465,882 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Sale of securities on an exchange or to another person at price $ 21.17 per share. | 13 Aug 2024 | 465,882 | 0 | - | 21.2 | 9,864,679 | Class A Common Stock |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 465,882 | 465,882 | - | 0 | Class A Common Stock | ||
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 413,098 | 413,098 | - | - | Common Stock | |
| Rezolve AI Ltd | Douglas M. Lurio | Director, Pres, Sec and Treas, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 403,941 | 0 | - | 0 | Common Stock | |
| Clarivate PLC | Matitiahu S. Shem Tov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 362,903 | 696,081 | - | 0 | Ordinary Shares | |
| Rezolve AI Ltd | Douglas M. Lurio | Director, Pres, Sec and Treas, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 353,941 | 403,941 | - | 0 | Common Stock | |
| Clarivate PLC | Jonathan Mark Collins | Executive Vice President/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 322,580 | 723,458 | - | 0 | Ordinary Shares | |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 318,822 | 0 | - | 0 | Class A Common Stock | |
| Compass Therapeutics Inc | Jonathan Anderman | Sr VP, Gen Counsel & Corp Sec | 13 Aug 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | ||
| Rezolve AI Ltd | Stephen P. Herbert | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 298,436 | 0 | - | 0 | Common Stock | |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 286,616 | 286,616 | - | - | Common Stock | |
| Amprius Tech Inc | Livingston L. Satterthwaite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 283,019 | 291,639 | - | 0 | Common stock | |
| Olaplex Holdings Inc | Catherine Dunleavy | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 268,817 | 1,075,269 | - | 0 | Common Stock | |
| Rezolve AI Ltd | Stephen P. Herbert | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 248,436 | 298,436 | - | 0 | Common Stock | |
| Bolt Projects Holdings Inc (Class A) | Cintia Nardi | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 227,068 | 227,068 | - | - | Common Stock | |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 220,600 | 899,212 | - | 44.0 | 9,708,606 | Common Stock |
| Coupang Inc (Class A) | Gaurav Anand | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 13 Aug 2024 | 200,000 | 1,937,500 | - | 22.8 | 4,550,000 | Class A Common Stock |
| Avalo Therapeutics Inc | Garry A. Neil | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 194,600 | 194,600 | - | - | Restricted Stock Units | |
| Avalo Therapeutics Inc | Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 186,700 | 186,700 | - | - | Stock Option (Right to Buy) | |
| Clarivate PLC | Melanie D. Margolin | EVP, Chief Admin & Legal Offcr | 13 Aug 2024 | 161,290 | 711,380 | - | 0 | Ordinary Shares | ||
| Clarivate PLC | Gordon Samson | President, IP | 13 Aug 2024 | 161,290 | 1,113,292 | - | 0 | Ordinary Shares | ||
| Clarivate PLC | Henry Levy | President, LS&H | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 161,290 | 586,332 | - | 0 | Ordinary Shares | |
| Clarivate PLC | Bar Veinstein | President, A&G | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 161,290 | 1,096,583 | - | 0 | Ordinary Shares | |
| Unilever PLC (ADR) | Nelson Peltz | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 47.11 per share. | 13 Aug 2024 | 155,000 | 32,794,772 (1%) | 0% | 47.1 | 7,302,050 | Ords |
| Bolt Projects Holdings Inc (Class A) | Randy Befumo | INTERIM CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 152,987 | 152,987 | - | - | Common Stock | |
| Trade Desk Inc (Class A) | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 98.17 per share. | 13 Aug 2024 | 150,000 | 96,910 (0%) | 0% | 98.2 | 14,725,500 | Class A Common Stock |
| Mueller Water Products Inc - Ordinary Shares - Series A | J Scott Hall | Senior Advisor | Sale of securities on an exchange or to another person at price $ 19.75 per share. | 13 Aug 2024 | 140,080 | 544,028 (0%) | 0% | 19.8 | 2,766,874 | Common Stock |
| Vertex Inc (Class A) | Eric C. Andersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 140,000 | 22,000 | - | - | Stock Option | |
| Vertex Inc (Class A) | Eric C. Andersen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 13 Aug 2024 | 140,000 | 223,014 | - | 2.5 | 350,000 | Class A Common Stock |
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 136,190 | 136,190 | - | - | Option (Right to Buy Common Stock) | |
| Rezolve AI Ltd | Thomas A. Decker | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 0 | - | 0 | Common Stock | |
| Rezolve AI Ltd | Celso L. White | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 0 | - | 0 | Common Stock | |
| Rezolve AI Ltd | Mohammad A. Khan | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 0 | - | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.17 per share. | 13 Aug 2024 | 120,000 | 447,838 | - | 3.2 | 380,400 | Common Stock, par value $0.01 per share |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 120,000 | 0 | - | - | Stock Option (right to buy) | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 13 Aug 2024 | 120,000 | 352,975 (0%) | 0% | 21.5 | 2,581,680 | Ordinary Shares |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 120,000 | 0 | - | - | Stock Option (right to buy) | |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 106,638 | 234,971 (0%) | 0% | 0 | Common Stock | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 13 Aug 2024 | 95,743 | 6,876,284 (10%) | 0% | 103.2 | 9,878,763 | Common Stock | |
| ASP Isotopes Inc | Todd Wider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 95,238 | 667,708 | - | - | Common Stock | |
| PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 90,774 | 90,774 | - | - | Employee Stock Option (right to buy) | |
| Techtarget Inc | Steven Niemiec | Chief Operating Officer & CRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 90,000 | 90,000 | - | - | Restricted Stock Units | |
| Rezolve AI Ltd | Thomas A. Decker | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 90,000 | 125,000 | - | 0 | Common Stock | |
| Rezolve AI Ltd | Celso L. White | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 90,000 | 125,000 | - | 0 | Common Stock | |
| Rezolve AI Ltd | Mohammad A. Khan | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 90,000 | 125,000 | - | 0 | Common Stock | |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 87,793 | 994,117 (1%) | 0% | 0 | American Depositary Shares | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 85,996 | 1,079,611 (2%) | 0% | - | Common Stock | |
| GrowGeneration Corp | Michael Salaman | Director, President | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 13 Aug 2024 | 85,301 | 1,425,376 (3%) | 0% | 1.9 | 160,195 | Common Stock |
| GrowGeneration Corp | Darren Lampert | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 13 Aug 2024 | 85,300 | 1,518,420 (4%) | 0% | 1.9 | 160,193 | Common Stock |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 82,576 | 993,614 (2%) | 0% | - | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.79 per share. | 13 Aug 2024 | 82,559 | 1,352,040 | - | 39.8 | 3,285,246 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.79 per share. | 13 Aug 2024 | 82,139 | 986,299 | - | 39.8 | 3,268,689 | Class A Common Stock |
| Vertex Inc (Class A) | Eric C. Andersen | Director | Sale of securities on an exchange or to another person at price $ 36.52 per share. | 13 Aug 2024 | 80,952 | 83,014 | - | 36.5 | 2,956,529 | Class A Common Stock |
| Clarivate PLC | William E. Graff | EVP, Chief Information Officer | 13 Aug 2024 | 80,645 | 425,347 | - | 0 | Ordinary Shares | ||
| ASP Isotopes Inc | Todd Wider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 77,626 | 572,470 | - | - | Common Stock | |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 77,520 | 38,760 | - | - | Employee Stock Option (Right to Buy) | |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 13 Aug 2024 | 77,520 | 673,290 (0%) | 0% | 27 | 2,093,040 | Class A Common Stock |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.69 per share. | 13 Aug 2024 | 77,520 | 750,810 (0%) | 0% | 13.7 | 1,061,249 | Class A Common Stock |
| Mueller Water Products Inc - Ordinary Shares - Series A | J Scott Hall | Senior Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.41 per share. | 13 Aug 2024 | 75,528 | 619,556 (0%) | 0% | 11.4 | 861,774 | Common Stock |
| Mueller Water Products Inc - Ordinary Shares - Series A | J Scott Hall | Senior Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 75,528 | 151,056 | - | - | Stock Option (Right to Buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Astera Labs Inc | Michael T. Tate | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 74,976 | 1,340,823 | - | 0 | Common Stock | |
| Commerce.com Inc - Ordinary Shares Series 1 | Jeffrey Gordon Richards | Director | Sale of securities on an exchange or to another person at price $ 5.61 per share. | 13 Aug 2024 | 73,860 | 196,247 | - | 5.6 | 414,325 | Series 1 Common Stock |
| Avalo Therapeutics Inc | Christopher Ryan Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 72,600 | 72,600 | - | - | Restricted Stock Units | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 70,660 | 911,037 (1%) | 0% | - | Common Stock | |
| Honest Co Inc (The ) | James D. White | Director | Sale of securities on an exchange or to another person at price $ 3.98 per share. | 13 Aug 2024 | 70,000 | 309,244 | - | 4.0 | 278,600 | Common Stock |
| Seer Inc (Class A) | Nicolas Henry Roelofs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 69,470 | 69,470 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 68,100 | 0 | - | - | Employee Stock Option (right to buy) | |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.17 per share. | 13 Aug 2024 | 66,166 | 706,160 (0%) | 0% | 66.2 | 4,377,986 | Common Stock |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 66,166 | 2,311,426 | - | - | Stock Option (right to buy) | |
| Bolt Projects Holdings Inc (Class A) | L. Jerry Fiddler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 65,985 | 65,985 | - | - | Common Stock | |
| Unilever PLC (ADR) | Nelson Peltz | Non-Executive Director | 13 Aug 2024 | 65,000 | 32,729,772 (1%) | 0% | 0 | Ords | ||
| Mueller Water Products Inc - Ordinary Shares - Series A | J Scott Hall | Senior Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.64 per share. | 13 Aug 2024 | 64,552 | 684,108 (0%) | 0% | 13.6 | 880,489 | Common Stock |
| Mueller Water Products Inc - Ordinary Shares - Series A | J Scott Hall | Senior Advisor | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 64,552 | 62,560 | - | - | Stock Option (Right to Buy) | |
| Bolt Projects Holdings Inc (Class A) | Fiddler L. Jerry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 62,461 | 62,461 | - | - | Common Stock | |
| FTAI infra Inc | Joseph P. Adams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.04 per share. | 13 Aug 2024 | 61,111 | 399,565 | - | 9.0 | 552,443 | Common Stock, par value $0.01 per share |
| Applovin Corp (Class A) | Matthew Stumpf | Chief Financial Officer (CFO) | Sale of securities on an exchange or to another person at price $ 79.63 per share. | 13 Aug 2024 | 60,215 | 254,858 | - | 79.6 | 4,794,920 | Class A Common Stock |
| Vertex Inc (Class A) | Eric C. Andersen | Director | Sale of securities on an exchange or to another person at price $ 35.80 per share. | 13 Aug 2024 | 59,048 | 163,966 | - | 35.8 | 2,114,007 | Class A Common Stock |
| Morgan Stanley | Eric F. Grossman | Chief Legal/Admin Officer | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 58,705 | 200,032 (0%) | 0% | 0 | Common Stock | |
| AAON Inc | Norman H. Asbjornson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.71 per share. | 13 Aug 2024 | 57,480 | 62,615 (0%) | 0% | 15.7 | 903,011 | Common Stock, par value $.004 |
| AAON Inc | Norman H. Asbjornson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 57,480 | 0 | - | - | Stock Option (Right to Buy) | |
| Conoco Phillips | Timothy A. Leach | Director | Sale of securities on an exchange or to another person at price $ 108.11 per share. | 13 Aug 2024 | 55,500 | 455,909 (0%) | 0% | 108.1 | 6,000,255 | Common Stock |
| Mueller Ind Inc | Gregory L. Christopher | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 67.59 per share. | 13 Aug 2024 | 55,000 | 1,309,311 (2%) | 0% | 67.6 | 3,717,450 | Common Stock |
| Interface Inc | Bruce Andrew Hausmann | VP & CFO | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 13 Aug 2024 | 54,792 | 198,683 (0%) | 0% | 17 | 931,464 | Common Stock |
| Commerce.com Inc - Ordinary Shares Series 1 | Jeffrey Gordon Richards | Director | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 13 Aug 2024 | 51,817 | 144,430 | - | 5.5 | 283,076 | Series 1 Common Stock |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 51,498 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.01 per share. | 13 Aug 2024 | 51,498 | 673,290 (0%) | 0% | 27.0 | 1,390,940 | Class A Common Stock |
| Verra Mobility Corp (Class A) | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.62 per share. | 13 Aug 2024 | 51,498 | 724,788 (0%) | 0% | 12.6 | 649,905 | Class A Common Stock |
| Kinder Morgan (Class P) | Dax A. Sanders | VP (Pres., Products Pipelines) | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 13 Aug 2024 | 51,340 | 256,069 (0%) | 0% | 21.0 | 1,078,155 | Class P Common Stock |
| Myriad Genetics Inc | Paul J. Diaz | Director, President and CEO | 13 Aug 2024 | 50,980 | 992,378 (1%) | 0% | 28.2 | 1,436,616 | Common Stock | |
| Evolv Tech Holdings Inc (Class A) | David Mounts Gonzales | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 13 Aug 2024 | 50,000 | 120,544 | - | 3 | 150,000 | Class A Common Stock |
| First Horizon Corp | D. Bryan Jordan | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 50,000 | 1,925,685 (0%) | 0% | 0 | Common Stock | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 69,054 | - | 3.4 | 170,500 | Class A Common Stock | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 144,627 | - | - | Employee Stock Option (right to buy) | ||
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 194,627 | - | - | Employee Stock Option (right to buy) | ||
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 19,054 | - | 10 | 500,000 | Class A Common Stock | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 69,054 | - | 3.4 | 170,500 | Class A Common Stock | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 13 Aug 2024 | 50,000 | 19,054 | - | 10.0 | 501,550 | Class A Common Stock | |
| Warby Parker Inc (Class A) | Bradley E. Singer | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 13 Aug 2024 | 50,000 | 100,000 | - | 13 | 650,000 | Class A Common Stock |
| One Stop Systems Inc | Joseph M. Manko | Director | 13 Aug 2024 | 50,000 | 1,149,899 (7%) | 0% | 1.9 | 97,000 | Common Stock | |
| Ryan Specialty Holdings Inc (Class A) | Jeremiah R. Bickham | EVP & Chief Finical Officer | 13 Aug 2024 | 50,000 | 229,508 | - | 0 | Class B Common Stock | ||
| Ryan Specialty Holdings Inc (Class A) | Jeremiah R. Bickham | EVP & Chief Finical Officer | 13 Aug 2024 | 50,000 | 229,508 | - | - | Common Units | ||
| Ryan Specialty Holdings Inc (Class A) | Jeremiah R. Bickham | EVP & Chief Finical Officer | 13 Aug 2024 | 50,000 | 51,078 | - | 0 | Class A Common Stock | ||
| Seer Inc (Class A) | Nicolas Henry Roelofs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 46,886 | 57,913 | - | 0 | Class A Common Stock | |
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 333.40 per share. | 13 Aug 2024 | 46,591 | 659,569 (0%) | 0% | 333.4 | 15,533,672 | Common Stock |
| eXp World Holdings Inc | Glenn Sanford | Director, CEO and Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.05 per share. | 13 Aug 2024 | 46,047 | 41,074,250 (63%) | 0% | 12.1 | 555,028 | Common Stock |
| Cardinal Health | Jason M. Hollar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 45,958 | 260,769 (0%) | 0% | 0 | Common Shares | |
| Cardinal Health | Stephen M. Mason | CEO, GMPD Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 45,958 | 83,313 (0%) | 0% | 0 | Common Shares | |
| Mueller Ind Inc | Gregory L. Christopher | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 67.73 per share. | 13 Aug 2024 | 45,000 | 1,264,311 (2%) | 0% | 67.7 | 3,047,850 | Common Stock |
| Fortive | James A. Lico | Director, President and CEO | 13 Aug 2024 | 44,583 | 0 (0%) | 0% | 0 | Common Stock | ||
| SS&C Tech Holdings Inc | Smita Conjeevaram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.94 per share. | 13 Aug 2024 | 42,500 | 52,076 (0%) | 0% | 36.9 | 1,569,950 | Common Stock |
| SS&C Tech Holdings Inc | Smita Conjeevaram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 42,500 | 0 | - | - | Stock Option (right to buy) | |
| SS&C Tech Holdings Inc | Smita Conjeevaram | Director | Sale of securities on an exchange or to another person at price $ 70.82 per share. | 13 Aug 2024 | 42,500 | 9,576 (0%) | 0% | 70.8 | 3,009,973 | Common Stock |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 41,976 | 41,976 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 41,976 | 0 | - | 0 | Class A Common Stock | |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 41,976 | 41,976 | - | 0 | Class A Common Stock | ||
| Cardinal Health | Jessica L. Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 41,780 | 111,068 (0%) | 0% | 0 | Common Shares | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 13 Aug 2024 | 41,667 | 48,866,215 (28%) | 0% | 9.8 | 408,837 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 13 Aug 2024 | 41,667 | 48,848,287 (28%) | 0% | 9.8 | 408,837 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 41,667 | 500,000 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 41,667 | 541,667 | - | - | Nonqualified Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 40,805 | 40,805 | - | - | Employee Stock Option (right to buy) | |
| Qorvo Inc | Robert A. Bruggeworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 40,268 | 225,650 (0%) | 0% | 0 | Common Stock | |
| Conagra Brands | Thomas M. McGough | EVP & COO | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 13 Aug 2024 | 40,000 | 161,442 (0%) | 0% | 30.3 | 1,211,600 | Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 39,375 | 573,885 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 39,375 | 613,260 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Aug 2024 | 39,375 | 1,380,343 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Aug 2024 | 39,375 | 1,355,968 | - | 2.2 | 87,413 | Class A Common Stock |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | 13 Aug 2024 | 38,816 | 97,268 | - | 10.3 | 397,864 | Common Stock | |
| Harte-Hanks Inc | Bradley L. Radoff | Director | Purchase of securities on an exchange or from another person at price $ 7.23 per share. | 13 Aug 2024 | 38,007 | 279,290 (4%) | 0% | 7.2 | 274,665 | Common Stock |
| CubeSmart | Christopher P. Marr | Director, CEO | Sale of securities on an exchange or to another person at price $ 48.66 per share. | 13 Aug 2024 | 37,906 | 576,836 (0%) | 0% | 48.7 | 1,844,506 | Common |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.00 per share. | 13 Aug 2024 | 37,906 | 614,742 (0%) | 0% | 25 | 947,650 | Common |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 37,906 | 0 | - | - | Stock Option (right to buy) | |
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 36,861 | 36,861 | - | - | Option (Right to Buy Common Stock) | |
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 36,861 | 36,861 | - | - | Option (Right to Buy Common Stock) | |
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 36,861 | 36,861 | - | - | Option (Right to Buy Common Stock) | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.75 per share. | 13 Aug 2024 | 36,122 | 329,691 (0%) | 0% | 103.8 | 3,747,658 | Ordinary Shares |
| Lattice Semiconductor Corp | David Jeffrey Richardson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 35,846 | 0 (0%) | 0% | 0 | Common Stock | |
| Lattice Semiconductor Corp | David Jeffrey Richardson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 35,846 | 0 (0%) | 0% | 0 | Common Stock | |
| Lattice Semiconductor Corp | David Jeffrey Richardson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 35,846 | 35,846 (0%) | 0% | 0 | Common Stock | |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.69 per share. | 13 Aug 2024 | 35,593 | 327,838 | - | 3.7 | 131,338 | Common Stock, par value $0.01 per share |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 35,593 | 0 | - | - | Stock Option (right to buy) | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.99 per share. | 13 Aug 2024 | 35,593 | 232,975 (0%) | 0% | 25.0 | 889,611 | Ordinary Shares |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 35,593 | 0 | - | - | Stock Option (right to buy) | |
| ARS Pharma Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.76 per share. | 13 Aug 2024 | 35,401 | 1,446,494 | - | 12.8 | 451,880 | Common Stock |
| ARS Pharma Inc | Sarina Tanimoto | CHIEF MEDICAL OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.76 per share. | 13 Aug 2024 | 35,401 | 1,446,494 | - | 12.8 | 451,880 | Common Stock |
| ARS Pharma Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 13 Aug 2024 | 35,363 | 1,548,499 | - | 12.8 | 451,441 | Common Stock |
| ARS Pharma Inc | Sarina Tanimoto | CHIEF MEDICAL OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 13 Aug 2024 | 35,363 | 1,548,499 | - | 12.8 | 451,441 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 5.02 per share. | 13 Aug 2024 | 35,000 | 1,116,249 (4%) | 0% | 5.0 | 175,844 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 5.01 per share. | 13 Aug 2024 | 35,000 | 1,081,249 (4%) | 0% | 5.0 | 175,228 | Common Stock |
| Bolt Projects Holdings Inc (Class A) | M. Klosk Steven | Director | 13 Aug 2024 | 35,000 | 35,000 | - | - | Common Stock | ||
| Bolt Projects Holdings Inc (Class A) | Steven Klosk M. | Director | 13 Aug 2024 | 35,000 | 0 | - | - | Class B Common Stock | ||
| Vistra | Stephanie Zapata Moore | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 80.37 per share. | 13 Aug 2024 | 34,714 | 127,174 (0%) | 0% | 80.4 | 2,789,964 | Common Stock |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 34,493 | 34,494 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | 13 Aug 2024 | 34,493 | 34,493 | - | 0 | Class A Common Stock | ||
| Goodyear Tire & Rubber Co. | John E. Mcglade | Director | Purchase of securities on an exchange or from another person at price $ 8.03 per share. | 13 Aug 2024 | 31,408 | 31,408 (0%) | 0% | 8.0 | 252,206 | Common Stock |
| Envista Holdings Corp | Paul A. Keel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.87 per share. | 13 Aug 2024 | 30,000 | 402,605 (0%) | 0% | 16.9 | 506,100 | Common Stock |
| ARS Pharma Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.64 per share. | 13 Aug 2024 | 30,000 | 36,024 | - | 0.6 | 19,200 | Common Stock |
| ARS Pharma Inc | Brian T. Dorsey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 30,000 | 111,828 | - | - | Stock Option (Right to Buy) | |
| ARS Pharma Inc | Brian T. Dorsey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 13 Aug 2024 | 30,000 | 6,024 | - | 13 | 390,000 | Common Stock |
| Keros Therapeutics Inc | Carl L. Gordon | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 29,400 | 119,522 | - | 44.0 | 1,293,894 | Common Stock |
| Broadridge Financial | Timothy C. Gokey | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 29,381 | 195,000 (0%) | 0% | 0 | Common Stock | |
| Cardinal Health | Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 29,245 | 54,087 (0%) | 0% | 0 | Common Shares | |
| Leslies Inc | Lorna E. Nagler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 29,029 | 29,029 | - | - | Restricted Stock Units | |
| Unilever PLC (ADR) | Nelson Peltz | Non-Executive Director | 13 Aug 2024 | 28,923 | 32,758,695 (1%) | 0% | 0 | Ords | ||
| Applied Industrial Tech Inc | Neil A. Schrimsher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 27,477 | 227,103 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 27,200 | 0 | - | - | Employee Stock Option (right to buy) | |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | 13 Aug 2024 | 27,191 | 124,459 | - | 2.5 | 67,978 | Common Stock | |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | 13 Aug 2024 | 27,191 | 300,000 | - | - | Stock Option (Right to Buy) | ||
| Ryan Specialty Holdings Inc (Class A) | Jeremiah R. Bickham | EVP & Chief Finical Officer | 13 Aug 2024 | 26,233 | 24,845 | - | 65.2 | 1,709,862 | Class A Common Stock | |
| Astera Labs Inc | Philip Mazzara | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 25,304 | 382,824 | - | 0 | Common Stock | |
| N-able Inc | Peter C. Anastos | EVP, GC, Secretary | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 13 Aug 2024 | 25,010 | 342,351 | - | 12.8 | 320,378 | Common Stock, par value $0.001 per share |
| National Vision Holdings Inc | D. Randolph Peeler | Director | Purchase of securities on an exchange or from another person at price $ 10.57 per share. | 13 Aug 2024 | 25,000 | 207,880 (0%) | 0% | 10.6 | 264,200 | Common Stock |
| Verra Mobility Corp (Class A) | Craig C. Conti | CFO | Sale of securities on an exchange or to another person at price $ 26.92 per share. | 13 Aug 2024 | 25,000 | 47,210 (0%) | 0% | 26.9 | 672,910 | Class A Common Stock |
| Warby Parker Inc (Class A) | Bradley E. Singer | Director | Purchase of securities on an exchange or from another person at price $ 12.63 per share. | 13 Aug 2024 | 25,000 | 125,000 | - | 12.6 | 315,750 | Class A Common Stock |
| One Stop Systems Inc | Joseph M. Manko | Director | 13 Aug 2024 | 25,000 | 1,174,899 (7%) | 0% | 2.0 | 49,750 | Common Stock | |
| PubMatic Inc Ordinary Shares | Steven Pantelick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 25,000 | 174,999 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| PubMatic Inc Ordinary Shares | Steven Pantelick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 25,000 | 310,860 | - | - | Class B Common Stock | |
| Avalo Therapeutics Inc | Gilla Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | June S. Almenoff | Director | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | ||
| Avalo Therapeutics Inc | Mitchell Chan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Aaron Kantoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Samantha Truex | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Jonathan Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 24,600 | 24,600 | - | - | Stock Option (Right to Buy) | |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 13 Aug 2024 | 24,512 | 1,056,737 (3%) | 0% | 5.0 | 123,418 | Common Stock |
| Harte-Hanks Inc | Bradley L. Radoff | Director | Purchase of securities on an exchange or from another person at price $ 7.29 per share. | 13 Aug 2024 | 23,900 | 315,183 (5%) | 0% | 7.3 | 174,284 | Common Stock |
| Ryan Specialty Holdings Inc (Class A) | Jeremiah R. Bickham | EVP & Chief Finical Officer | 13 Aug 2024 | 23,767 | 1,078 | - | 64.4 | 1,530,614 | Class A Common Stock | |
| KVH Ind Inc | David M. Tolley | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 23,615 | 43,371 (0%) | 0% | 0 | Common Stock | |
| CS Disco Inc | Scott Anthony Hill | Director | Purchase of securities on an exchange or from another person at price $ 5.39 per share. | 13 Aug 2024 | 23,554 | 187,615 | - | 5.4 | 126,956 | Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 142.67 per share. | 13 Aug 2024 | 23,138 | 895,457 (1%) | 0% | 142.7 | 3,301,098 | Class A Common Stock |
| Fabrinet | Seamus Grady | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.75 per share. | 13 Aug 2024 | 22,901 | 65,176 (0%) | 0% | 217.8 | 4,986,693 | Ordinary Shares |
| KVH Ind Inc | David B. Kagan | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 22,839 | 41,664 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Paul J. Diaz | Director, President and CEO | 13 Aug 2024 | 22,808 | 1,043,358 (1%) | 0% | 28.2 | 642,729 | Common Stock | |
| PMV Pharmaceuticals Inc | Deepika Jalota | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 22,674 | 0 | - | - | Employee Stock Option (right to buy) | |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 22,423 | 0 | - | 0 | Class A Common Stock | |
| Bolt Projects Holdings Inc (Class A) | Daniel Matthew Widmaier | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 22,117 | 22,117 | - | - | Option (Right to Buy Common Stock) | |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 22,117 | 22,117 | - | - | Option (Right to Buy Common Stock) | |
| Universal Insurance Holdings Inc | Jon W. Springer | Director | Sale of securities on an exchange or to another person at price $ 19.37 per share. | 13 Aug 2024 | 22,096 | 509,072 (1%) | 0% | 19.4 | 427,964 | Common Stock |
| Pebblebrook Hotel Trust | Jon E. Bortz | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 12.21 per share. | 13 Aug 2024 | 22,000 | 1,341,284 (1%) | 0% | 12.2 | 268,620 | Common Shares |
| KVH Ind Inc | Charles R. Trimble | Director | 13 Aug 2024 | 21,952 | 184,121 (1%) | 0% | 0 | Common Stock | ||
| Insteel Ind Inc | H. O. Woltz | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 21,735 | 21,735 | - | - | Option (right to buy) | |
| NCR Voyix Corp | Eric Schoch | EVP & President, Retail | 13 Aug 2024 | 21,692 | 101,671 (0%) | 0% | 12.2 | 264,425 | Common Stock | |
| Fabrinet | Seamus Grady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 21,303 | 66,774 (0%) | 0% | 0 | Ordinary Shares | |
| Fabrinet | Seamus Grady | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 21,303 | 88,077 (0%) | 0% | 0 | Ordinary Shares | |
| California Resources Corp - Ordinary Shares - New | Christian S. Kendall | Director | Purchase of securities on an exchange or from another person at price $ 47.97 per share. | 13 Aug 2024 | 20,895 | 24,600 (0%) | 0% | 48.0 | 1,002,291 | Common Stock |
| Mosaic | Walter F. Precourt | SVP - Chief Admin Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 20,762 | 0 (0%) | 0% | 0 | Common Stock | |
| Mosaic | Walter F. Precourt | SVP - Chief Admin Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 20,762 | 176,430 (0%) | 0% | 0 | Common Stock | |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Sale of securities on an exchange or to another person at price $ 132.55 per share. | 13 Aug 2024 | 20,651 | 9,715 (0%) | 0% | 132.5 | 2,737,290 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 142.30 per share. | 13 Aug 2024 | 20,322 | 845,492 (1%) | 0% | 142.3 | 2,891,810 | Class A Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 73.11 per share. | 13 Aug 2024 | 20,052 | 48,844,334 (28%) | 0% | 73.1 | 1,465,913 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share. | 13 Aug 2024 | 20,000 | 68,306 (0%) | 0% | 399.7 | 7,993,200 | Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 20,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Apollo Commercial Real Estate Finance Inc | Scott S. Prince | Director | Sale of securities on an exchange or to another person at price $ 10.06 per share. | 13 Aug 2024 | 20,000 | 51,154 (0%) | 0% | 10.1 | 201,224 | Common Stock |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 13 Aug 2024 | 20,000 | 6,856,284 (10%) | 0% | 103.8 | 2,076,600 | Common Stock | |
| GrowGeneration Corp | Michael Salaman | Director, President | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 13 Aug 2024 | 19,996 | 1,445,372 (3%) | 0% | 1.9 | 37,992 | Common Stock |
| GrowGeneration Corp | Darren Lampert | Director, CEO | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 13 Aug 2024 | 19,996 | 1,538,416 (4%) | 0% | 1.9 | 37,992 | Common Stock |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Sale of securities on an exchange or to another person at price $ 131.48 per share. | 13 Aug 2024 | 19,714 | 30,366 (0%) | 0% | 131.5 | 2,591,997 | Class A Common Stock |
| Mosaic | Walter F. Precourt | SVP - Chief Admin Officer | Sale of securities on an exchange or to another person at price $ 27.95 per share. | 13 Aug 2024 | 19,654 | 156,776 (0%) | 0% | 27.9 | 549,329 | Common Stock |
| Fortinet | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 71.21 per share. | 13 Aug 2024 | 19,404 | 48,824,548 (28%) | 0% | 71.2 | 1,381,782 | Common Stock |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 19,321 | 354,877 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | Thad Jampol | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 39.01 per share. | 13 Aug 2024 | 19,321 | 749,652 | - | 39.0 | 753,782 | Common Stock |
| Intapp Inc | Thad Jampol | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 13 Aug 2024 | 19,321 | 768,973 | - | 4.0 | 77,091 | Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 143.22 per share. | 13 Aug 2024 | 19,189 | 826,303 (1%) | 0% | 143.2 | 2,748,233 | Class A Common Stock |
| Quanterix Corp | Masoud Toloue | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 13 Aug 2024 | 19,000 | 354,119 (1%) | 0% | 10.9 | 207,100 | Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.30 per share. | 13 Aug 2024 | 18,953 | 807,350 (1%) | 0% | 144.3 | 2,735,001 | Class A Common Stock |
| AMKOR Tech Inc | Megan Faust | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 18,023 | 71,046 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 143.77 per share. | 13 Aug 2024 | 17,703 | 877,754 (1%) | 0% | 143.8 | 2,545,074 | Class A Common Stock |
| Applied Industrial Tech Inc | Neil A. Schrimsher | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.43 per share. | 13 Aug 2024 | 17,692 | 209,411 (0%) | 0% | 197.4 | 3,492,932 | Common Stock |
| DXC Tech Co | David Lawrence Herzog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 17,400 | 90,701 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Stephen M. Kelsey | See Remarks | Sale of securities on an exchange or to another person at price $ 42.98 per share. | 13 Aug 2024 | 16,667 | 269,073 (0%) | 0% | 43.0 | 716,389 | Common Stock |
| Revolution Medicines Inc | Stephen M. Kelsey | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 13 Aug 2024 | 16,667 | 285,740 (0%) | 0% | 4.1 | 68,168 | Common Stock |
| Revolution Medicines Inc | Stephen M. Kelsey | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 16,667 | 56,665 | - | - | Stock Option (Right to Buy) | |
| KVH Ind Inc | Stephen H. Deckoff | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 16,630 | 16,630 (0%) | 0% | 0 | Common Stock | |
| authID Inc | Michael L. Koehneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,627 | 15,627 | - | - | Stock Options | |
| authID Inc | Jacqueline L. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,627 | 15,627 | - | - | Stock Options | |
| authID Inc | Ken Jisser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,627 | 15,627 | - | - | Stock Options | |
| authID Inc | Michael C. Thompson | Director | 13 Aug 2024 | 15,627 | 15,627 | - | - | Stock Options | ||
| authID Inc | Kunal Mehta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,627 | 15,627 | - | - | Stock Options | |
| Applied Industrial Tech Inc | Neil A. Schrimsher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,210 | 15,210 | - | - | Stock Appreciation Rights | |
| CXApp Inc (Class A) | Di-Ann Eisnor | Director | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 13 Aug 2024 | 15,000 | 64,120 | - | 3.4 | 50,700 | Class A Common Stock |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 13 Aug 2024 | 15,000 | 324,627 | - | - | Class A Common Stock | ||
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 13 Aug 2024 | 15,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 577,268 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 13 Aug 2024 | 15,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Class B Common Stock | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 592,268 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | 13 Aug 2024 | 15,000 | 324,627 | - | - | Class A Common Stock | ||
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 13.02 per share. | 13 Aug 2024 | 15,000 | 3,520,901 | - | 13.0 | 195,245 | Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 13 Aug 2024 | 15,000 | 1,365,343 | - | 6.4 | 95,252 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 13 Aug 2024 | 15,000 | 1,340,968 | - | 6.3 | 95,183 | Class A Common Stock |
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Mats L. Wahlstrom | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | David J. Matlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Andrew C. von Eschenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Liselotte Hyveled | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Arjun JJ Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Anil K. Singhal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | George Kelly Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| M & T Bank | Kirk W. Walters | Director | Sale of securities on an exchange or to another person at price $ 24.61 per share. | 13 Aug 2024 | 14,847 | 24,744 | - | 24.6 | 365,324 | Series H. Perpetual Non-Cumulative Preferred Stock |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 14,744 | 14,744 | - | - | Option (Right to Buy Common Stock) | |
| Fabrinet | Harpal Gill | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.75 per share. | 13 Aug 2024 | 14,657 | 37,300 (0%) | 0% | 217.8 | 3,191,562 | Ordinary Shares |
| ARS Pharma Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 13 Aug 2024 | 14,637 | 1,583,862 | - | 11.8 | 172,327 | Common Stock |
| ARS Pharma Inc | Sarina Tanimoto | CHIEF MEDICAL OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 13 Aug 2024 | 14,637 | 1,583,862 | - | 11.8 | 172,327 | Common Stock |
| ARS Pharma Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 13 Aug 2024 | 14,599 | 1,481,895 | - | 11.8 | 171,908 | Common Stock |
| ARS Pharma Inc | Sarina Tanimoto | CHIEF MEDICAL OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 13 Aug 2024 | 14,599 | 1,481,895 | - | 11.8 | 171,908 | Common Stock |
| PureCycle Tech Inc | Brad S. Kalter | General Counsel and Secretary | 13 Aug 2024 | 14,300 | 158,208 | - | 0 | Common Stock | ||
| Palo Alto | Arora Nikesh | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 334.44 per share. | 13 Aug 2024 | 14,115 | 645,454 (0%) | 0% | 334.4 | 4,720,592 | Common Stock |
| Neurocrine Biosciences Inc | Matthew C. Abernethy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.60 per share. | 13 Aug 2024 | 14,100 | 45,628 (0%) | 0% | 73.6 | 1,037,760 | Common Stock |
| Neurocrine Biosciences Inc | Matthew C. Abernethy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 14,100 | 0 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences Inc | Matthew C. Abernethy | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 150.38 per share. | 13 Aug 2024 | 14,100 | 31,528 (0%) | 0% | 150.4 | 2,120,347 | Common Stock |
| Weave Comm Inc | Tyler Newton | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Aug 2024 | 14,093 | 7,594,626 | - | 0 | Common Stock, par value $0.0001 per share | |
| Cardinal Health | Deborah Weitzman | CEO, PSS Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 13,926 | 48,490 (0%) | 0% | 0 | Common Shares | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.12 per share. | 13 Aug 2024 | 13,861 | 1,068,438 | - | 39.1 | 542,262 | Class A Common Stock |
| Regeneron Pharma | Andrew J Murphy | EVP Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1141.49 per share. | 13 Aug 2024 | 13,637 | 54,669 (0%) | 0% | 1141.5 | 15,566,499 | Common Stock |
| Fabrinet | Harpal Gill | PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 13,634 | 38,323 (0%) | 0% | 0 | Ordinary Shares | |
| Fabrinet | Harpal Gill | PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 13,634 | 51,957 (0%) | 0% | 0 | Ordinary Shares | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 13,605 | 0 | - | - | Employee Stock Option (right to buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.12 per share. | 13 Aug 2024 | 13,441 | 1,434,599 | - | 39.1 | 525,762 | Class A Common Stock |
| Corning | John Z. Zhang | SVP&GM Display, MCE & Asia | Sale of securities on an exchange or to another person at price $ 39.73 per share. | 13 Aug 2024 | 12,918 | 0 (0%) | 0% | 39.7 | 513,206 | Common Stock |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.17 per share. | 13 Aug 2024 | 12,838 | 460,676 | - | 3.2 | 40,696 | Common Stock, par value $0.01 per share |
| FTAI infra Inc | Joseph P. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,838 | 0 | - | - | Stock Option (right to buy) | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,838 | 0 | - | - | Stock Option (right to buy) | |
| FTAI Aviation Ltd (Class A) | Joseph P. Adams | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.51 per share. | 13 Aug 2024 | 12,838 | 365,813 (0%) | 0% | 21.5 | 276,197 | Ordinary Shares |
| Contineum Therapeutics Inc (Class A) | Stephen L. Huhn | CMO & Sr VP, Clinical Dev. | 13 Aug 2024 | 12,800 | 12,800 | - | 1.0 | 12,928 | Class A Common Stock | |
| Contineum Therapeutics Inc (Class A) | Stephen L. Huhn | CMO & Sr VP, Clinical Dev. | 13 Aug 2024 | 12,800 | 161,394 | - | - | Stock Option (right to buy) | ||
| AMMO Inc | Anthony Louis Tate | VP OF SALES, AMMO | 13 Aug 2024 | 12,533 | 456,355 | - | 1.5 | 18,549 | Common Stock | |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.00 per share. | 13 Aug 2024 | 12,500 | 29,970 (0%) | 0% | 47 | 587,500 | Class A Common Stock |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.47 per share. | 13 Aug 2024 | 12,500 | 42,470 (0%) | 0% | 26.5 | 330,875 | Class A Common Stock |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,500 | 0 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,500 | 12,500 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,500 | 25,000 | - | - | Director Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.45 per share. | 13 Aug 2024 | 12,500 | 17,470 (0%) | 0% | 12.5 | 155,625 | Class A Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | SEVP & General Counsel | 13 Aug 2024 | 12,500 | 18,960 (0%) | 0% | 15.2 | 189,500 | Class A Common Stock | |
| Microstrategy Inc (Class A) | W. Ming Shao | SEVP & General Counsel | 13 Aug 2024 | 12,500 | 0 | - | - | Employee Stock Option (Right to buy) | ||
| DXC Tech Co | Robert F. Woods | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 69,131 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | David A. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 46,900 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Carrie W. Teffner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 32,800 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Dawn Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 39,400 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Akihiko Washington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 39,400 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Pinkie D. Mayfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 24,700 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Karl Racine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 28,500 (0%) | 0% | 0 | Common Stock | |
| DXC Tech Co | Anthony Gonzalez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 12,300 | 28,500 (0%) | 0% | 0 | Common Stock | |
| Encompass Health Corp | Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 12,260 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Douglas E. Coltharp | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.83 per share. | 13 Aug 2024 | 12,260 | 148,487 (0%) | 0% | 35.8 | 439,276 | Encompass Health Common Stock |
| Encompass Health Corp | Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.33 per share. | 13 Aug 2024 | 12,162 | 136,325 (0%) | 0% | 86.3 | 1,049,945 | Encompass Health Common Stock |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Sale of securities on an exchange or to another person at price $ 21.17 per share. | 13 Aug 2024 | 12,070 | 22,423 | - | 21.2 | 255,573 | Class A Common Stock |
| Harte-Hanks Inc | Bradley L. Radoff | Director | Purchase of securities on an exchange or from another person at price $ 7.08 per share. | 13 Aug 2024 | 11,993 | 291,283 (4%) | 0% | 7.1 | 84,910 | Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.58 per share. | 13 Aug 2024 | 11,940 | 865,814 (1%) | 0% | 144.6 | 1,726,289 | Class A Common Stock |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 11,795 | 11,795 | - | - | Option (Right to Buy Common Stock) | |
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | 13 Aug 2024 | 11,625 | 0 | - | - | Stock Option (Right to Buy) | ||
| CCC Intelligent Soln Holdings Inc | Mary Jo Prigge | See Remarks | 13 Aug 2024 | 11,625 | 136,084 | - | 2.5 | 29,063 | Common Stock | |
| Neurocrine Biosciences Inc | Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 11,570 | 0 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences Inc | Gary A. Lyons | Director | Sale of securities on an exchange or to another person at price $ 150.43 per share. | 13 Aug 2024 | 11,570 | 119,047 (0%) | 0% | 150.4 | 1,740,450 | Common Stock |
| Neurocrine Biosciences Inc | Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.76 per share. | 13 Aug 2024 | 11,570 | 130,617 (0%) | 0% | 42.8 | 494,733 | Common Stock |
| Trinseo PLC | Mark E. Tomkins | Director | 13 Aug 2024 | 11,142 | 46,724 (0%) | 0% | 2.5 | 28,301 | Ordinary Shares | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 141.88 per share. | 13 Aug 2024 | 11,126 | 918,595 (1%) | 0% | 141.9 | 1,578,584 | Class A Common Stock |
| Abeona Therapeutics Inc | Eric Crombez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 11,044 | 11,044 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Bernhardt G. Zeiher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 11,044 | 11,044 (0%) | 0% | 0 | Common Stock | |
| Qorvo Inc | Grant A. Brown | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 10,813 | 56,929 (0%) | 0% | 0 | Common Stock | |
| Netflix | David Hyman | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 650.00 per share. | 13 Aug 2024 | 10,794 | 31,610 (0%) | 0% | 650 | 7,016,100 | Common Stock |
| nVent Electric PLC | Michael B. Faulconer | President - Thermal Management | 13 Aug 2024 | 10,741 | 19,765 (0%) | 0% | 63.4 | 680,450 | Ordinary Shares | |
| AAON Inc | Norman H. Asbjornson | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.77 per share. | 13 Aug 2024 | 10,291 | 52,324 (0%) | 0% | 87.8 | 903,241 | Common Stock, par value $.004 |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 145.13 per share. | 13 Aug 2024 | 10,192 | 797,158 (1%) | 0% | 145.1 | 1,479,205 | Class A Common Stock |
| Corning | John P. Bayne | Retired Senior Vice President | 13 Aug 2024 | 10,000 | 15,658 (0%) | 0% | 40 | 400,000 | Common Stock - Jt. Tenant W/wife | |
| Jackson Fin Inc (Class A) | Scott E. Romine | President and CEO, JNLD | Sale of securities on an exchange or to another person at price $ 82.52 per share. | 13 Aug 2024 | 10,000 | 62,591 | - | 82.5 | 825,200 | Common Stock |
| Apollo Commercial Real Estate Finance Inc | Scott S. Prince | Director | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 13 Aug 2024 | 10,000 | 71,154 (0%) | 0% | 10.0 | 100,438 | Common Stock |
| Apollo Commercial Real Estate Finance Inc | Scott S. Prince | Director | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 13 Aug 2024 | 10,000 | 41,154 (0%) | 0% | 10.1 | 100,990 | Common Stock |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 79.88 per share. | 13 Aug 2024 | 10,000 | 448,239 (1%) | 0% | 79.9 | 798,812 | Common stock, par value $0.00001 per share |
| Futurefuel Corp | Richard P. Rowe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 10,000 | 10,000 | - | - | Stock Options (Right to Buy) | |
| Fluence Energy Inc (Class A) | Herman E. Bulls | Director | Purchase of securities on an exchange or from another person at price $ 16.81 per share. | 13 Aug 2024 | 10,000 | 65,861 | - | 16.8 | 168,140 | Class A Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.87 per share. | 13 Aug 2024 | 10,000 | 686,744 (0%) | 0% | 13.9 | 138,700 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 10,000 | 80,000 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 10,000 | 90,000 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 10,000 | 100,000 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 57.95 per share. | 13 Aug 2024 | 10,000 | 676,744 (0%) | 0% | 57.9 | 579,490 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.87 per share. | 13 Aug 2024 | 10,000 | 686,744 (0%) | 0% | 13.9 | 138,700 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.87 per share. | 13 Aug 2024 | 10,000 | 686,744 (0%) | 0% | 13.9 | 138,700 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 56.25 per share. | 13 Aug 2024 | 10,000 | 676,744 (0%) | 0% | 56.2 | 562,490 | Common Stock |
| N-able Inc | Frank Colletti | EVP, Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 12.86 per share. | 13 Aug 2024 | 10,000 | 443,475 | - | 12.9 | 128,600 | Common Stock, par value $0.001 per share |
| Roblox Corp (Class A) | Mark Reinstra | Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.40 per share. | 13 Aug 2024 | 10,000 | 352,656 | - | 3.4 | 34,050 | Class A Common Stock |
| Roblox Corp (Class A) | Mark Reinstra | Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 10,000 | 398,528 | - | - | Stock Option (Right to Buy) | |
| Artivion Inc | Anthony B. Semedo | Director | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 13 Aug 2024 | 9,709 | 34,159 (0%) | 0% | 25.0 | 242,628 | Common Stock |
| Qorvo Inc | Paul J. Fego | SVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,694 | 46,806 (0%) | 0% | 0 | Common Stock | |
| Teradata Corp | Kathleen R. Cullen-Cote | Chief People Officer | Sale of securities on an exchange or to another person at price $ 25.94 per share. | 13 Aug 2024 | 9,683 | 114,627 (0%) | 0% | 25.9 | 251,177 | Common Stock |
| Avalo Therapeutics Inc | Gilla Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Avalo Therapeutics Inc | June S. Almenoff | Director | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | ||
| Avalo Therapeutics Inc | Mitchell Chan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Avalo Therapeutics Inc | Aaron Kantoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Avalo Therapeutics Inc | Samantha Truex | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Avalo Therapeutics Inc | Jonathan Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,500 | 9,500 | - | - | Restricted Stock Units | |
| Garmin | Min H. Kao | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 9,412 | 6,279,571 (3%) | 0% | 0 | Registered Shares | |
| Microstrategy Inc (Class A) | W. Ming Shao | SEVP & General Counsel | 13 Aug 2024 | 9,300 | 9,660 (0%) | 0% | 136.3 | 1,267,404 | Class A Common Stock | |
| Coherent Corp | Giovanni Barbarossa | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 9,161 | 218,318 (0%) | 0% | 0 | Common Stock | |
| Insteel Ind Inc | H. O. Woltz | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,806 | 8,806 | - | - | Restricted Stock Units | |
| Coherent Corp | Walter R. Bashaw | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,656 | 94,516 (0%) | 0% | 0 | Common Stock | |
| First Solar | Patrick Buehler | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 222.00 per share. | 13 Aug 2024 | 8,619 | 3,468 (0%) | 0% | 222 | 1,913,418 | Common Stock |
| Qorvo Inc | Steven Eric Creviston | SVP, Connectivity & Sensors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,576 | 88,900 (0%) | 0% | 0 | Common Stock | |
| National Cinemedia Inc | Lauren Zalaznick | Director | 13 Aug 2024 | 8,461 | 36,945 (0%) | 0% | 5.9 | 50,005 | Common Stock | |
| National Cinemedia Inc | Nicholas Bell | Director | Grant, award, or other acquisition of securities at price $ 5.91 per share. | 13 Aug 2024 | 8,461 | 36,945 (0%) | 0% | 5.9 | 50,005 | Common Stock |
| ASP Isotopes Inc | Michael Gorley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,380 | 101,838 | - | - | Common Stock | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 13 Aug 2024 | 8,315 | 309,627 | - | 36.3 | 301,695 | Class A Common Stock |
| Roblox Corp (Class A) | Mark Reinstra | Gen. Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 38.86 per share. | 13 Aug 2024 | 8,300 | 344,356 | - | 38.9 | 322,536 | Class A Common Stock |
| AMKOR Tech Inc | Mark N. Rogers | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,260 | 33,540 (0%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Farshad Haghighi | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,260 | 16,614 (0%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Kevin Engel | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,260 | 8,260 (0%) | 0% | 0 | Common Stock | |
| Broadridge Financial | Christopher John Perry | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,139 | 64,427 (0%) | 0% | 0 | Common Stock | |
| Pebblebrook Hotel Trust | Jon E. Bortz | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 12.34 per share. | 13 Aug 2024 | 8,000 | 1,349,284 (1%) | 0% | 12.3 | 98,720 | Common Shares |
| Phio Pharma Corp | Robert M. Infarinato | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,000 | 8,000 (0%) | 0% | 0 | Common stock, $0.0001 par value | |
| AMC Networks Inc (Class A) | Leonard Tow | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 7,947 | 7,947 (0%) | 0% | 0 | AMC Networks Inc. Class A Common Stock | |
| AMC Networks Inc (Class A) | Leonard Tow | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 7,947 | 0 (0%) | 0% | 0 | AMC Networks Inc. Class A Common Stock | |
| DaVita | Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | Sale of securities on an exchange or to another person at price $ 146.21 per share. | 13 Aug 2024 | 7,857 | 83,011 (0%) | 0% | 146.2 | 1,148,766 | Common Stock |
| AMKOR Tech Inc | Megan Faust | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.16 per share. | 13 Aug 2024 | 7,723 | 63,323 (0%) | 0% | 32.2 | 248,372 | Common Stock |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 13 Aug 2024 | 7,633 | 309,627 | - | 36.3 | 276,929 | Class A Common Stock |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.16 per share. | 13 Aug 2024 | 7,610 | 50,080 (0%) | 0% | 30.2 | 229,518 | Class A Common Stock |
| Microstrategy Inc (Class A) | Carl J. Rickertsen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 7,610 | 0 | - | - | Director Stock Option (Right to buy) | |
| Extreme Networks Inc | Ingrid J. Burton | Director | Sale of securities on an exchange or to another person at price $ 13.53 per share. | 13 Aug 2024 | 7,521 | 67,188 (0%) | 0% | 13.5 | 101,759 | Common Stock |
| Full House Resorts Inc | Eric J. Green | Director | Purchase of securities on an exchange or from another person at price $ 5.14 per share. | 13 Aug 2024 | 7,500 | 178,523 (0%) | 0% | 5.1 | 38,543 | Common Stock |
| Qorvo Inc | Philip J. Chesley | SVP, High Performance Analog | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 7,457 | 43,351 (0%) | 0% | 0 | Common Stock | |
| Bolt Projects Holdings Inc (Class A) | David Nate Breslauer | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 7,372 | 7,372 | - | - | Option (Right to Buy Common Stock) | |
| Doximity Inc (Class A) | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.54 per share. | 13 Aug 2024 | 7,367 | 317,260 | - | 35.5 | 261,821 | Class A Common Stock |
| Viavi Soln Inc | Paul McNab | EVP, Chief Mktg & Stgy Officer | Sale of securities on an exchange or to another person at price $ 7.52 per share. | 13 Aug 2024 | 7,324 | 35,631 (0%) | 0% | 7.5 | 55,076 | Common Stock |
| Fabrinet | Csaba Sverha | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 7,243 | 21,316 (0%) | 0% | 0 | Ordinary Shares | |
| Fabrinet | Csaba Sverha | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 7,243 | 28,559 (0%) | 0% | 0 | Ordinary Shares | |
| NiSource | Melody Birmingham | EVP & President NI Utilities | Sale of securities on an exchange or to another person at price $ 31.54 per share. | 13 Aug 2024 | 7,151 | 41,923 (0%) | 0% | 31.5 | 225,578 | Common Stock |
| Sezzle Inc | Paul M. Purcell | Former Director | Sale of securities on an exchange or to another person at price $ 125.39 per share. | 13 Aug 2024 | 7,119 | 262,597 | - | 125.4 | 892,659 | Common Stock |
| Garmin | Min H. Kao | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2024 | 7,060 | 12,048,999 (6%) | 0% | 0 | Registered Shares |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.